Northeast Pharmaceutical Group Co., Ltd

Northeast Pharmaceutical was born in the ranks of the Northeast People's Liberation Army. It is the eldest son of the pharmaceutical industry of the Republic and the cradle and incubator of chemical and organic synthetic pharmaceuticals in the country. Northeast Pharmaceutical was founded in Jiamusi in 1946 and named Northeast Health Technology Factory. It moved to Shenyang in 1949 and was renamed as the state-owned Northeast Pharmaceutical General Factory in 1953. It has been 68 years since then. Northeast Pharmaceutical Group Co., Ltd. ("Northeast Pharmaceutical" for short) was established in June 1993 and employs more than 10,000 people. The company has total assets of 7.63 billion yuan, annual sales revenue of nearly 9 billion yuan, and annual export earnings of approximately US$100 million. It is a large state-owned comprehensive pharmaceutical enterprise. The company's shares were listed on the Shenzhen Stock Exchange in 1996, stock code: 000597. As an important pharmaceutical production and export base in China, Northeast Pharmaceutical has a pharmaceutical research institute, a design institute and a quality inspection center, as well as a "postdoctoral" scientific research workstation. It has gathered a large number of prestigious top-level experts and management talents, formed a relatively complete scientific research, production, operation and training system, and has strong new drug research and development and technological innovation capabilities. The company mainly produces antibiotics, vitamins, cardiovascular and cerebrovascular products, digestive system products, antiviral products, natural drugs, antipyretic and analgesic products, anti-AIDS products, narcotic and psychotropic drugs, family planning drugs, health care products, and diagnostics. There are 12 major series including reagents and more than 400 kinds of chemical raw materials, pharmaceutical intermediates and preparation products. The leading products are exported to more than 100 countries and regions. At present, the company has 351 national approval numbers for preparation products, and 244 regulated drugs have entered the Category A and B drug catalog of the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog", including 123 essential drug product approval numbers. The company has a complete quality management and control system to control the entire process of procurement, production, warehousing, transportation, and sales. The product complies with the latest versions of EP8 and USP36 standards, and has overall passed GMP certification and GSP certification. It has passed the three integrated certifications of quality management system ISO9001:2008, international environmental management system ISO14001:2004, and occupational health and safety management system GB/T28001-2011. Facing future development, Northeast Pharmaceutical takes "all for health, challenges the unknown and impossible" as its core values, aims at international and domestic advanced benchmark enterprises, and is committed to achieving leapfrog in the fields of chemical pharmaceuticals, biopharmaceuticals, pharmaceutical business, pharmaceutical chemical industry construction, and medical care. development, and strive to build a first-class domestic and internationally renowned large-scale pharmaceutical enterprise group.